Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus

Diabetes/Metabolism Research and Reviews

Volumn 29, Issue 5, 2013, Pages 363-368

  Huang, Gan ^a   Xiang, Yufei ^a   Pan, Lingling ^a   Li, Xia ^a   Luo, Shuoming ^a   Zhou, Zhiguang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

cell function; Autoantibody; Latent autoimmune diabetes in adults; Type 2 diabetes mellitus; Zinc transporter 8

Indexed keywords

AUTOANTIBODY; C PEPTIDE; CHOLESTEROL; GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; INSULINOMA ASSOCIATED PROTEIN 2 ANTIBODY; LIPID; PROTEIN ANTIBODY; RADIOLIGAND; UNCLASSIFIED DRUG; ZINC TRANSPORTER 8 AUTOANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BINDING ASSAY; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; DIABETES MELLITUS; FEMALE; HUMAN; LATENT AUTOIMMUNE DIABETES MELLITUS IN ADULT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

Β-CELL FUNCTION; AUTOANTIBODY; LATENT AUTOIMMUNE DIABETES IN ADULTS; TYPE 2 DIABETES MELLITUS; ZINC TRANSPORTER 8;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RADIOLIGAND ASSAY; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8; SENSITIVITY AND SPECIFICITY;

EID: 84880000251     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2396     Document Type: Article

References (26)

1. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. PNAS 2007; 104: 17040-17045.
2. Wenzlau JM, Moua O, Sarkar SA, et al. SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes. Ann N Y Acad Sci 2008; 1150: 256-259.
3. Chistiakov DA, Voronova NV. Zn(2+)-transporter-8: a dual role in diabetes. Biofactors 2009; 35: 356-363.
4. Rutter GA. Think zinc: new roles for zinc in the control of insulin secretion. Islets 2010; 2: 49-50.
5. Kawasaki E, Nakamura K, Kuriya G, et al. Zinc transporter 8 autoantibodies in fulminant, acute-onset, and slow-onset patients with type 1 diabetes. Diabetes Metab Res Rev 2011; 27: 895-898.
6. Andersson C, Larsson K, Vaziri-Sani F, et al. The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity 2011; 44: 394-405.
7. Kawasaki E, Uga M, Nakamura K, et al. Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes. Diabetologia 2008; 51: 2299-2302.
8. Yang L, Luo S, Huang G, et al. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese. Diabetes Metab Res Rev 2010; 26: 579-584.
9. Lampasona V, Petrone A, Tiberti C, et al. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4. Diabetes Care 2010; 33: 104-108.
10. Trabucchi A, Faccinetti NI, Guerra LL, et al. Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype. Autoimmunity 2012; 45: 137-142.
11. World Health Organization, Department of Noncommunicable Disease Surveillance. Definition, Diagnosis and Classification of Diabetes and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and classification of diabetes. Geneva, Switzerland, World Health Org. 1999, p. 1-59.
12. Petersen JS, Hejnaes KR, Moody A, et al. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 1994; 43: 459-467.
13. Leslie RD, Williams R, Pozzilli P. Clinical review: type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow. J Clin Endocrinol Metab 2006; 91: 1654-1659.
14. Fourlanos S, Dotta F, Greenbaum CJ, et al. Latent autoimmune diabetes in adults(LADA) should be less latent. Diabetologia 2005; 48: 2206-2212.
15. Naik RG, Brooks-Worrell BM, Palmer JP. Latent autoimmune diabetes in adults. J Clin Endocrinol Metab 2009; 94: 4635-4644.
16. Turner R, Stratton I, Horton V, et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997; 350: 1288-1293.
17. Bottazzo GF, Bosi E, Cull CA, et al. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). Diabetologia 2005; 48: 703-708.
18. Tiberti C, Verrienti A, Fiore B, et al. IA-2 combined epitope assay: a new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes. Clin Immunol 2005; 115: 260-267.
19. Yang Z, Wang K, Li T, et al. Childhood diabetes in China. Enormous variation by place and ethnic group. Diabetes Care 1998; 21: 525-529.
20. Park Y, Hong S, Park L, et al. LADA prevalence estimation and insulin dependency during follow-up. Diabetes Metab Res Rev 2011; 27: 975-979.
21. Takeda H, Kawasaki E, Shimizu I, et al. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime study). Diabetes Care 2002; 25: 995-1001.
22. Turner R, Stratton I, Horton V, et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997; 350: 1288-1293.
23. El Muayed M, Billings LK, Raja MR, et al. Acute cytokine-mediated downregulation of the zinc transporter ZnT8 alters pancreatic beta-cell function. J Endocrinol 2010; 206: 159-169.
24. Notkins AL, Zhang B, Matsumoto Y, Lan MS. Comparison of IA-2 with IA-2beta and with six other members of the protein tyrosine phosphatase family: recognition of antigenic determinants by IDDM sera. J Autoimmun 1997; 10: 245-250.
25. Isomaa B, Almgren P, Henricsson M, et al. Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care 1999; 22: 1347-1353.
26. Davies H, Brophy S, Fielding A, et al. Latent autoimmune diabetes in adults (LADA) in South Wales: incidence and characterization. Diabet Med 2008; 25: 1354-1357.